首页> 美国卫生研究院文献>Advanced Pharmaceutical Bulletin >Preparation Evaluation andOptimization of Multiparticulate System of Mebendazole for Colon Targeted DrugDelivery by Using Natural Polysaccharides
【2h】

Preparation Evaluation andOptimization of Multiparticulate System of Mebendazole for Colon Targeted DrugDelivery by Using Natural Polysaccharides

机译:准备评估和甲苯达唑结肠靶向药物多颗粒体系的优化使用天然多糖进行递送

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Purpose: A Multiparticulate system of Mebendazole was developed for colon targeted drug delivery by using natural polysaccharides like Chitosan and Sodium-alginate beads. >Methods: Chitosan microspheres were formulated by using Emulsion crosslinking method using Glutaraldehyde as crosslinking agent. Sodium-alginate beads were formulated by using Calcium chloride as gelling agent. Optimization for Chitosan microspheres was carried out by using 23 full factorial design. 32 full factorial design was used for the optimization of Sodium-alginate beads. The formulated batches were evaluated for percentage yield, particle size measurement, flow properties, percent entrapment efficiency, Swelling studies. The formulations were subjected to Stability studies and In-vitro release study (with and without rat caecal content). Release kinetics data was subjected to different dissolution models. >Results: The formulated batches showed acceptable particle size range as well as excellent flow properties. Entrapment efficiency for optimized batches of Chitosanmicrospheres and sodium alginate beads was found to be 74.18% and 88.48%respectively. In-vitro release of drug for the optimized batches was found tobe increased in presence of rat caecal content. The best-fit models were koresmeyer-peppasfor Chitosan microspheres and zero order for sodium-alginate beads.>Conclusion: Chitosan and Sodium-alginate was used successfully for the formulation of Colon targetedMultiparticulate system.
机译:>目的:通过使用天然多糖(如壳聚糖和海藻酸钠珠)开发了甲苯甲唑多颗粒系统,用于结肠靶向药物递送。 >方法:以戊二醛为交联剂,采用乳液交联法制备壳聚糖微球。通过使用氯化钙作为胶凝剂配制海藻酸钠珠。利用2 3 全因子设计对壳聚糖微球进行了优化。 3 2 全因子设计用于优化海藻酸钠微珠。评价配制的批次的百分产率,粒度测量,流动性质,截留百分效率,溶胀研究。对该制剂进行稳定性研究和体外释放研究(有或没有大鼠盲肠含量)。释放动力学数据经过不同的溶出模型。 >结果:配制的批次显示出可接受的粒度范围以及出色的流动性。优化批次的壳聚糖的包封效率微球和藻酸钠微珠的含量分别为74.18%和88.48%分别。发现优化批次的药物体外释放在大鼠盲肠内容物存在时增加。最合适的模型是koresmeyer-peppas用于壳聚糖微球,海藻酸钠珠为零级。>结论:壳聚糖和海藻酸钠已成功用于结肠靶向治疗多颗粒系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号